The SA Journal Diabetes & Vascular Disease Volume 17 No 1 (July 2020)

23 / 42

SA JOURNAL OF DIABETES & VASCULAR DISEASE RESEARCH ARTICLE
VOLUME 17 NUMBER 1 • JULY 2020 21
3. Ali AT, Crowther NJ. Health risks associated with obesity. J Endocrinol Metab
Diabetes SA 2005; 10(2): 56–61.
4. World Health Organization. Global status report on noncommunicable diseases
2014. Geneva. Switzerland, 2015 (accessed 27 July 2018).
5. Bloom DE, Cafiero ET, Jane-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et
al. The global economic burden of non-communicable diseases. Geneva: World
Economic Forum, 2011.
6. Allen N, Berry JD, Ning H. Impact of blood pressure and blood pressure change
during middle age on the remaining lifetime risk for cardiovascular disease: the
cardiovascular lifetime risk pooling project. Circulation 2012; 125: 37.
7. Bonifonte A, Ayer T, Veledar E. Antecedent blood pressure as a predictor of
cardiovascular disease. Am Soc Hypertens 2015; 9: 690–696.
8. American Heart Association. What is high blood pressure. .
org/HEARTORG/Conditions/HighBloodPressure/AboutHighBloodPressure/What -
is-High-Blood-Pressure_UCM_301759_Article.jsp (accessed 13 Jul 2015).
9. Akpan EE, Ekrikpo UE, Udo AI. Prevalence of hypertension in Akwa Ibom State,
South-South Nigeria: Rural versus Urban Communities Study. Int J Hypertens
2015; 20: 1–5.
10. Lim SS, Vos T, Flaxman AD. A comparative risk assessment of burden of disease
and injury attributable to 67 risk factors and risk factor clusters in 21 regions,
1990–2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lancet 2012; 380: 2224–2260.
11. Díaz A, Ferrante D. Trends in prevalence of hypertension in Argentina in the last
25 years: a systematic review of observational studies. Rev Panam Salud Publica
2015; 38: 496–503.
12. Guwatudde D, Nankya-Mutyoba J, Kalyesubula R. The burden of hypertension in
sub-Saharan Africa: a four-country cross sectional study. BMC Public Health 2015;
15: 1211.
13. Van de Vijver S, Akinyi H, Oti S. Status report on hypertension in Africa-consultative
review for the 6th session of the African Union Conference of Ministers of Health
on NCD’s. Pan Afr Med J 2013; 16: 1–17.
14. Hasumi T, Jacobsen KH. Hypertension in South African adults: results of a
nationwide survey. J Hypertens 2012; 30: 2098–104.
15. Rayner B. What is the prevalence of hypertension? Health 24: hypertension, 1.
hypertension-20130205 (accessed 3 Jul 2016).
16. Nguyen T, Lau DCW. Obesity epidemic and its impact on hypertension (Review).
Can J Cardiol 2012; 28(3): 326–333.
17. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among
US adults according to the new Joint National Committee guidelines. Arch Intern
Med 2004; 164 : 2126–2134.
18. Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd-Jones D, Sowers J.
Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment −a
position paper of the Obesity Society and the American Society of Hypertension. J
Clin Hypertens 2013; 21: 8–24.
19. Pausova Z, Jomphe M, Houde L, Vezina H, Orlov SN, Gossard F, et al. A
genealogical study of essential hypertension with and without obesity in French
Canadians. Obes Res 2002; 10: 463–470.
20. Hamet P, Merlo E, Seda O, Broeckel U, Tremblay J, Kaldunski M, et al. Quantitative
founder-effect analysis of French Canadian families identifies specific loci
contributing to metabolic phenotypes of hypertension. Am J Hum Genet 2005;
76: 815–822.
21. Jensen MD. Role of body fat distribution and the metabolic complications of
obesity. J Clin Endocrinol Metab 2008; 93: S57–S63.
22. Seravalle G, Grassi G. Sympathetic nervous system, hypertension, obesity and
metabolic syndrome. High Blood Press Cardiovasc Prev 2016; 23: 175–179.
23. Sironi AM, Gastaldelli A, Mari A, Ciociaro D, Positano V, Postano V, et al. Visceral
fat in hypertension: influence on insulin resistance and B-cell function. J Hypertens
2004; 44: 127–133.
24. Vuvor F. Correlation of body mass index and blood pressure of adults of 30–50
years of age in Ghana. J Health Res Rev 2017; 4 : 115–121.
25. Jogunola OO, Awoyemi AO. Prevalence of sedentary lifestyle among bankers in
Ilorin metropolis. Niger J Med Rehab 2012; 5(12):44–50.
26. Jans MP, Proper KI, Hildebrandt VH. Sedentary behavior in Dutch workers:
differences between occupations and business sectors. Am J Prev Med 2007;
33(6):450–4.
27. Undhad A, Bharodiya PJ, Sonani RP. Correlates of hypertension among the bank
employees of Surat city of Gujarat. Nat J Res Commun Med 2011; 2: 123.
28. Bosu WK. The prevalence, awareness and control of hypertension among workers
in West Africa: a systematic review. Glob Health Action 2015; 8.
29. Amidu N, Alhassan A, Obirikorang C, Feglo P, Majeed SF, Timmy-Donkoh E,
Afful D. Sero-prevalence of hepatitis B surface (HBsAg) antigen in three densely
populated communities in Kumasi, Ghana. J Med Biomed Sci 2012; 1(2): 59–65.
30. Uwanuruochi K, Ukpabi OJ, Onwuta CN, Onwubere BJ, Anisiuba BC, Michael FS.
Cardiovascular risk factors in adult staff of Federal Medical Centre, Umuahia: a
comparison with other Nigerian studies. West Afr J Med 2013; 32(4): 243–247.
31. Bosu WK. Determinants of mean blood pressure and hypertension among
workers in West Africa. Int J Hypertens 2016: 1–19.
32. Funke O, Ibrahim KS. Blood pressure and body mass index among Jos University
Teaching Hospital Staff. Transnat J Sci Technol 2013; 3(9): 73–83.
33. Oladimeji AM, Fawole O, Nguku P, Nsubuga P. Prevalence and factors associated
with hypertension and obesity among civil servants in Kaduna State. Pan Afr Med
J 2014; 18(1): 18–30.
34. Schutte AE, Huisman HW, van Rooyen JM. Should obesity be blamed for the
high prevalence rates of hypertension in black South African women? J Hum
Hypertens 2008; 22(8): 528–536.
35. Aladeneyi I, Adeneyi OV, Owolabi EO, Fawole O, Adeolu M, Goon DT, Ajayi
AI. Prevalence, awareness and correlates of hypertension among urban public
workers in Ondo State, Nigeria. J Health Allied Scs 2017; 16(3): 1.
36. Statistics South Africa: Community Survey, 2007, Basic Results Municipalities.
South Africa: Report available on Statistics South Africa website: www. Statssa.
. retrieved on 9 June 2017.
37. Pescatello LS, Arena R, Riebe D Paul D, Thompson P.D. ACSM Guidelines for
Exercise Testing and Prescription. 9th edn. Philadelphia: Wolters Kluwer/
Lippincott Williams & Wilkins, 2014.
38. National Institutes of Health clinical guidelines on the identification, evaluation
and treatment of overweight and obesity in adults – the evidence report. Obes
Res 1998; 6: 51S–209S.
BISOPROLOL:
• HIGHLY SELECTIVE ß-BLOCKER
• 24 HOUR BP REDUCTION
• DOSING FLEXIBILITY
BILOCOR 5, 10. Each tablet contains 5, 10 mg bisoprolol fumarate respectively. S3 A38/5.2/0053, 0051.
NAM NS2 06/5.2/0061, 0062. For full prescribing information, refer to the professional information approved
by SAHPRA, 23 July 2010. BILOCOR CO 2,5/6,25, 5/6,25, 10/6,25. Each tablet contains 2,5, 5, 10 mg
bisoprolol fumarate respectively and 6,25 mg hydrochlorothiazide. S3 A44/7.1.3/1010, 1011, 1012. NAM NS2
13/7.1.3/0260, 0261, 0262. For full prescribing information, refer to the professional information approved by
SAHPRA, 6 May 2019. BRH560/05/2020.
CUSTOMER CARE LINE 0860 PHARMA (742 762) / +27 21 707 7000